|
1
|
Gupta N, Cullison C, Mally A, Xiang L, Hill ST, Beveridge MG. Certain public-reported immune-mediated adverse events for PD-1 inhibitors in melanoma occur at higher rates than in clinical trials. J Eur Acad Dermatol Venereol 2021; 35:e667-e670. [PMID: 34014567 DOI: 10.1111/jdv.17373] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2021] [Revised: 03/30/2021] [Accepted: 04/28/2021] [Indexed: 11/29/2022]
Affiliation(s)
- N Gupta
- Case Western Reserve University School of Medicine, Cleveland, OH, USA
| | - C Cullison
- Case Western Reserve University School of Medicine, Cleveland, OH, USA
| | - A Mally
- Case Western Reserve University School of Medicine, Cleveland, OH, USA
| | - L Xiang
- Case Western Reserve University School of Medicine, Cleveland, OH, USA
| | - S T Hill
- Department of Dermatology, University Hospitals Cleveland Medical Center, Cleveland, OH, USA
| | - M G Beveridge
- Department of Dermatology, University Hospitals Cleveland Medical Center, Cleveland, OH, USA
| |
Collapse
|
|
2
|
Cullison C, Zheng D, Levoska M, Scott J, Bordeaux J. 436 Identifying locations of Merkel cell carcinoma associated with higher disease-specific mortality. J Invest Dermatol 2021. [DOI: 10.1016/j.jid.2021.02.459] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|